Related Experiment Video
Updated: Mar 26, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Risk Adjustment Tools for Learning Health Systems: A Comparison of DxCG and CMS-HCC V21
Todd H Wagner1,2,3, Anjali Upadhyay4, Elizabeth Cowgill4
1Health Economics Resource Center (HERC), VA Palo Alto, Menlo Park, CA. todd.wagner@va.gov.
The DxCG risk score showed improved fit over the CMS V21 model, but recalibrating V21 with pharmacy data created comparable risk scores. Healthcare systems can tailor V21 for better performance.
Area of Science:
- Health Services Research
- Health Economics
- Biostatistics
Background:
- Accurate patient risk adjustment is crucial for healthcare resource allocation and performance evaluation.
- Existing risk adjustment models, such as the Centers for Medicare and Medicaid Services (CMS) V21, may not fully capture the complexity of healthcare costs.
- The Department of Veterans Affairs (VA) manages a large and diverse patient population with unique healthcare needs.
Purpose of the Study:
- To compare the predictive accuracy of the DxCG (Verisk) risk score with the CMS V21 risk score using VA administrative data.
- To evaluate the impact of incorporating pharmacy data on risk score performance.
- To assess the feasibility of recalibrating the CMS V21 model for the VA population.
Main Methods:
- Analysis of administrative and pharmacy data from the VA for fiscal years 2010-2011.
- Regression analysis to model total annual VA costs based on predicted risk scores from DxCG and CMS V21.
- Model fit was assessed using R-squared, root mean squared error, mean absolute error, and Hosmer-Lemeshow tests.
- Creation of six distinct analytical files representing different patient subgroups.
Main Results:
- The DxCG risk score incorporating pharmacy data demonstrated significantly improved model fit compared to the CMS V21 model.
- Recalibrating the CMS V21 model using VA pharmacy data resulted in risk scores with fit statistics comparable to the DxCG model.
- Both models showed varying performance across different patient subgroups.
Conclusions:
- While DxCG with pharmacy data offers enhanced predictive fit, the CMS V21 model can be recalibrated using additional variables, such as pharmacy data, to achieve comparable performance within specific healthcare systems like the VA.
- Tailoring risk adjustment models to specific patient populations and data sources is essential for accurate healthcare cost prediction and resource management.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
10:33Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
Published on: September 4, 2017
Related Concept Videos
Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Hazard Ratio
For example, in a clinical trial...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...